Jörg König

Novel drug transporter substrates identification: an innovative approach based on metabolomic profiling, in silico ligand screening and biological validation.

S. Masuda, A. Nies, K. Inui, 2023, Pharmacological Research.

Double‐transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations

C. Hoffmann, Jörg König, Martin F. Fromm, 2011, British journal of pharmacology.

Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3

H. Glaeser, M. Fromm, H. Sticht, 2010, British journal of pharmacology.

Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO)

M. Fromm, J. König, A. Gessner, 2018, Scientific Reports.

Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on OATPs and OCT1

H. Glaeser, I. Bachmakov, Jörg König, 2008 .

New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans.

F. Müller, P. Stopfer, A. Gessner, 2024, Clinical pharmacology and therapeutics.